Technology | Mammography | April 05, 2017

New EMPIRE technology applies iterative and machine learning algorithms that provide a clearer, more concise 3-D breast reconstruction on Siemens’ Mammomat Inspiration digital mammography system

Siemens Healthineers, High Definition Breast Tomosynthesis, FDA approval, Mammomat Inspiration, DBT, mammography, SBI, RSNA 2017

April 5, 2017 — Siemens Healthineers announced that the U.S. Food and Drug Administration (FDA) has approved High Definition Breast Tomosynthesis. This unique form of digital breast tomosynthesis (DBT) includes new algorithms designed to deliver a heightened level of sensitivity to breast cancer detection and diagnosis over 2-D mammography alone. 

High Definition Breast Tomosynthesis builds on the established DBT platform from Siemens Healthineers with what the company calls the industry’s widest tomo sweep of 50 degrees. Siemens also said it delivers images of exceptional clarity, and is the first solution approved for 3-D-only mammograms. 

High Definition Breast Tomosynthesis incorporates new EMPIRE (Enhanced Multiple Parameter Iterative Reconstruction) technology, a combination of iterative and machine learning algorithms that provide a clearer, more concise 3-D reconstruction.

While EMPIRE technology has been approved as a 3-D-only exam, it also includes Insight 2-D and 3-D — what Siemens calls the industry’s first synthetic software-generated visualization of tomosynthesis volumes in both 2-D and 3-D. Insight 2-D allows breast imagers to obtain a 2-D image from the EMPIRE 3-D image set, providing them with a navigational support tool to their 3-D-only exams without subjecting patients to added dose. Insight 3-D adds new depth to the visualization of the breast anatomy.

High Definition Breast Tomosynthesis is available as an option on the company’s Mammomat Inspiration with Tomosynthesis Option digital mammography system.

For more information: www.usa.healthcare.siemens.com


Related Content

News | Breast Imaging

June 25, 2025 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time June 25, 2025
arrow
News | Women's Health

June 23, 2025 — Susan G. Komen, the world’s leading breast cancer organization, recently announced it is awarding $10.8 ...

Time June 23, 2025
arrow
Feature | Women's Health | Christine Murray

In breast cancer detection, speed and accuracy are more than clinical goals – they can significantly increase chances ...

Time June 17, 2025
arrow
News | PET Imaging

May 30, 2025 — GE HealthCare recently announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) ...

Time May 30, 2025
arrow
News | Imaging Software Development

May 27, 2025 — DeepLook Medical, a company advancing medical imaging through visual enhancement technology, recently ...

Time May 28, 2025
arrow
News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
Subscribe Now